Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bilger

Showing results (321-330 of 405) with videos related to

Pageof 41
Sort By:
Pathologie-Biologie|September 10, 2013
[How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, or syphilis IgM positive serology test]R Duléry, C Giraud, J-L Beaumont, et al.
European Journal of Gastroenterology & Hepatology|April 10, 2019
Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?Filiz Akyuz, Bilger Cavus, Raim Iliaz, et al.
Bone Marrow Transplantation|March 12, 2014
Allo-SCT for  Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)X Cahu, P Chevallier, A Clavert, et al.
Pathologie-Biologie|September 10, 2013
[How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant positive pregnancy test and monoclonal gammapathy]R Duléry, C Giraud, J-L Beaumont, et al.
Hepatology Forum|October 12, 2023
Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score's prediction factor for survival?Sami Evirgen, Bilger Cavus, Suut Gokturk, et al.
Balkan Medical Journal|March 24, 2023
Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational StudyAyşe Serra Artan, Şafak Mirioğlu, Zulal İstemihan, et al.
Journal of Clinical Medicine|June 12, 2026
Exocrine Pancreatic Insufficiency in Diabetes: Association with Cardiovascular Disease and Insulin TherapyMelek Balamir, Bartu Avcı, Elara Coşan, et al.
Experimental Hematology|October 11, 2003
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimenCatherine Faucher, Mohamad Mohty, Norbert Vey, et al.
Bone Marrow Transplantation|September 10, 2005
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantationV Ivanov, C Faucher, M Mohty, et al.
Blood|December 1, 2016
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHDGérard Socié, Stéphane Vigouroux, Ibrahim Yakoub-Agha, et al.
Pageof 41

Showing results (321-330 of 405) with videos related to

Sort By:
Pageof 41
Pathologie-Biologie|September 10, 2013
[How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, or syphilis IgM positive serology test]R Duléry, C Giraud, J-L Beaumont, et al.
European Journal of Gastroenterology & Hepatology|April 10, 2019
Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?Filiz Akyuz, Bilger Cavus, Raim Iliaz, et al.
Bone Marrow Transplantation|March 12, 2014
Allo-SCT for  Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)X Cahu, P Chevallier, A Clavert, et al.
Pathologie-Biologie|September 10, 2013
[How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant positive pregnancy test and monoclonal gammapathy]R Duléry, C Giraud, J-L Beaumont, et al.
Hepatology Forum|October 12, 2023
Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score's prediction factor for survival?Sami Evirgen, Bilger Cavus, Suut Gokturk, et al.
Balkan Medical Journal|March 24, 2023
Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational StudyAyşe Serra Artan, Şafak Mirioğlu, Zulal İstemihan, et al.
Journal of Clinical Medicine|June 12, 2026
Exocrine Pancreatic Insufficiency in Diabetes: Association with Cardiovascular Disease and Insulin TherapyMelek Balamir, Bartu Avcı, Elara Coşan, et al.
Experimental Hematology|October 11, 2003
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimenCatherine Faucher, Mohamad Mohty, Norbert Vey, et al.
Bone Marrow Transplantation|September 10, 2005
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantationV Ivanov, C Faucher, M Mohty, et al.
Blood|December 1, 2016
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHDGérard Socié, Stéphane Vigouroux, Ibrahim Yakoub-Agha, et al.
Pageof 41